BioCentury
ARTICLE | Clinical News

Patanase olopatadine hydrochloride regulatory update

April 21, 2008 7:00 AM UTC

FDA approved an NDA from Alcon for Patanase olopatadine nasal spray to treat seasonal allergic rhinitis in patients 12 years and older. The company plans to launch the twice-daily intranasal formulati...